The single-use bioreactor market is expected to be one of the fastest-growing segments in the bioprocessing industry over the next few years. This is due to the increasing demand for biopharmaceuticals and biologic products, as well as the cost and time savings associated with single-use systems. Additionally, the increasing adoption of single-use technologies, such as single-use bioreactors, is expected to drive the growth of the market. Companies are focusing on the development of next-generation bioreactors that can improve process efficiency, reduce costs, and increase production capacity. In addition, key players are focusing on increasing the automation of bioreactors to reduce labor costs and increase process control.

Single-Use Bioreactors Market in terms of revenue was estimated to be worth $4.2 billion in 2023 and is poised to reach $10.0 billion by 2028, growing at a CAGR of 19.0% from 2023 to 2028 according to a new report by MarketsandMarkets™. Factors such as the increasing adoption of single-use bioreactors among startups and SMEs, lower operational complexity of single-use bioreactors compared to conventional stainless-steel bioreactors, reduced energy and water consumption, growing size of the biologics and biosimilars market, and technological advancements in single-use bioreactors.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=49113750

Browse in-depth TOC on “Single-Use Bioreactors Market”

408 – Tables
48 – Figures
345 – Pages

Single-Use Bioreactors Market Scope:

The monoclonal antibodies segment accounted for the largest share of the type of molecule segment in the single-use bioreactors market in 2022.

Based on the type of molecule, the global single-use bioreactors market is segmented into monoclonal antibodies (mAbs), vaccines, gene-modified cells, stem cells, and other molecules. The monoclonal antibodies segment accounted for the largest share of the global single-use bioreactors market in 2022 owing to increasing demand for single-use bioreactors in the manufacturing of mAbs, and factors such as low investment costs and a reduction in time-intensive changeover procedures.

The mammalian cells segment accounted for the fastest growing share of the type of cell segment in the single-use bioreactors market in 2022.

Based on the type of cell, the global single-use bioreactors market is segmented into mammalian cells, bacterial cells, yeast cells, and other cells. In 2022, the mammalian cells segment accounted for the largest share of the market owing to increasing adoption of mammalian cells due to their post-translational modification capacity and human protein-like molecular structure assembly are expected to propel market growth.

The Asia Pacific region is the fastest-growing region of the single-use bioreactors market in 2022.

Based on the region, the single-use bioreactors market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific market is expected to register the highest CAGR during the forecast period. Factors such as the growing biopharmaceutical industry, rising investments by pharmaceutical & biotechnology companies, and the growing number of CROs & CMOs in several Asia Pacific countries are supporting the growth of the market in the region.

Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=49113750

Single-Use Bioreactors Market Dynamics:

Drivers:

1. Increasing adoption of SUBs among small companies and startups
2. Reduced automation complexity
3. Ease in the cultivation of marine organisms
4. Reduced energy and water consumption
5. Growing biologics market
6. Technological advancements in SUBs
7. Increasing biopharmaceutical R&D

Restraints:

1. Regulatory concerns related to SUBs
2. Issues related to leachables and extractables

Opportunities:

1. Patent expiry
2. Emerging markets

Challenges:

1. Need for improved single-use sensors
2. Standardization of single-use designs

Key Market Players:

Key players in the single-use bioreactors Market are Sartorius AG (Germany), Thermo Fisher Scientific (US), Danaher Corporation (US), and Merck Millipore (Germany).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=49113750

Single-Use Bioreactors Market Advantages:

• Cost Efficiency: Single-use bioreactors are cost-efficient, as they require fewer amounts of investments in terms of purchase, operation and maintenance. This, in turn, reduces the overall cost of production.
• Easy to Install and Operate: Single-use bioreactors are easy to install and operate, as they require minimal training and do not require complex infrastructure. This makes them an ideal choice for small-scale production.
• Increased Productivity: The use of single-use bioreactors can increase productivity, as they can be used to perform multiple processes in a single batch. This reduces the time required to complete the process.
• Reduced Risk of Contamination: Single-use bioreactors reduce the risk of contamination, as they do not require cleaning between batches. This enables manufacturers to produce high-quality products with minimal risk of contamination.
• Flexibility: Single-use bioreactors provide manufacturers with flexibility, as they can be used for a variety of processes and products. This reduces the cost of production, as manufacturers do not need to purchase multiple bioreactors for different processes.

About MarketsandMarkets™:

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.